The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates

Background: Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside monitoring tools might be of additional value in the pharmacodynamic (PD) assessment of su...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/27107
Acceso en línea:
https://doi.org/10.2174/1381612823666170918124419
https://repository.urosario.edu.co/handle/10336/27107
Palabra clave:
Pharmacodynamics
Neonate
Monitoring
Hemodynamics
Cerebral activity
Central nervous system
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_ea9f4c69d7f86bd256c6728584a950dd
oai_identifier_str oai:repository.urosario.edu.co:10336/27107
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 1e0fd7f0-251b-422b-a97e-5961db2b3861-1c9fafab1-fb47-4e52-93de-ff70fcf410d8-1df8f51ae-6ef0-4179-a77b-d75be3a821dc-1e2fc5044-be17-4fc6-9212-6261406e8bd2-121e3cc2b-385f-4821-a9ca-d9d7303f84ce-138de6b05-427b-4843-8821-5161b28c7324-12020-08-19T14:41:01Z2020-08-19T14:41:01Z2017Background: Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside monitoring tools might be of additional value in the pharmacodynamic (PD) assessment of such drugs in neonates. Methods: We aim to provide an overview of the frequently used monitoring tools to assess drug effects on the hemodynamic status as well as the cerebral circulation, oxygenation and cerebral metabolism in neonates. Results: The use of blood pressure measurements, heart rate variability, functional echocardiography, nearinfrared spectroscopy and (amplitude-integrated) electroencephalography in neonates is discussed, as well as new parameters introduced by these tools. Based on the ‘brain circulation model’, the hemodynamic effects on the brain and their interplay are summarized. In this model, 3 processes (i.e. blood processes, vascular smooth muscle processes and tissue processes) and 3 mechanisms (i.e. autoregulation, blood flow metabolism coupling and cerebral oxygen balance) are distinguished, which all may be influenced by drug administration. Finally, propofol, sevoflurane, midazolam and inotropes are used as examples of which PD has been studied using the available hemodynamic and/or cerebral monitoring tools. Conclusion: The implementation of (non-)invasive monitoring tools to document hemodynamic and cerebral PD effects in neonates is of relevance both in a neonatal research and intensive clinical care setting. We highlight the need to integrate these tools in future PD research. Furthermore, besides short-term drug effects, long-term outcome of drug therapy in neonates also warrants further attention.application/pdfhttps://doi.org/10.2174/1381612823666170918124419ISSN: 1381-6128EISSN: 1873-4286https://repository.urosario.edu.co/handle/10336/27107engBentham Science Publishers5963No. 385955Current Pharmaceutical DesignVol. 23Current Pharmaceutical Design, ISSN: 1381-6128;EISSN: 1873-4286, Vol.23, No.38 (2017); pp. 5955-5963 https://www.eurekaselect.com/155663/articleRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecCurrent Pharmaceutical Designinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURPharmacodynamicsNeonateMonitoringHemodynamicsCerebral activityCentral nervous systemThe use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonatesEl uso de monitorización hemodinámica y cerebral para estudiar la farmacodinámica en recién nacidosarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Smits, A.Thewissen, L.Dereymaeker, A.Dempsey, E.Caicedo, A.Naulaers, G.10336/27107oai:repository.urosario.edu.co:10336/271072021-06-03 00:50:05.795https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
dc.title.TranslatedTitle.spa.fl_str_mv El uso de monitorización hemodinámica y cerebral para estudiar la farmacodinámica en recién nacidos
title The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
spellingShingle The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
Pharmacodynamics
Neonate
Monitoring
Hemodynamics
Cerebral activity
Central nervous system
title_short The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
title_full The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
title_fullStr The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
title_full_unstemmed The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
title_sort The use of hemodynamic and cerebral monitoring to study pharmacodynamics in neonates
dc.subject.keyword.spa.fl_str_mv Pharmacodynamics
Neonate
Monitoring
Hemodynamics
Cerebral activity
Central nervous system
topic Pharmacodynamics
Neonate
Monitoring
Hemodynamics
Cerebral activity
Central nervous system
description Background: Drugs acting on the cardiovascular and central nervous system often display relatively fast clinical responses, which may differ in neonates compared to children and adults. Introduction of bedside monitoring tools might be of additional value in the pharmacodynamic (PD) assessment of such drugs in neonates. Methods: We aim to provide an overview of the frequently used monitoring tools to assess drug effects on the hemodynamic status as well as the cerebral circulation, oxygenation and cerebral metabolism in neonates. Results: The use of blood pressure measurements, heart rate variability, functional echocardiography, nearinfrared spectroscopy and (amplitude-integrated) electroencephalography in neonates is discussed, as well as new parameters introduced by these tools. Based on the ‘brain circulation model’, the hemodynamic effects on the brain and their interplay are summarized. In this model, 3 processes (i.e. blood processes, vascular smooth muscle processes and tissue processes) and 3 mechanisms (i.e. autoregulation, blood flow metabolism coupling and cerebral oxygen balance) are distinguished, which all may be influenced by drug administration. Finally, propofol, sevoflurane, midazolam and inotropes are used as examples of which PD has been studied using the available hemodynamic and/or cerebral monitoring tools. Conclusion: The implementation of (non-)invasive monitoring tools to document hemodynamic and cerebral PD effects in neonates is of relevance both in a neonatal research and intensive clinical care setting. We highlight the need to integrate these tools in future PD research. Furthermore, besides short-term drug effects, long-term outcome of drug therapy in neonates also warrants further attention.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-08-19T14:41:01Z
dc.date.available.none.fl_str_mv 2020-08-19T14:41:01Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.2174/1381612823666170918124419
dc.identifier.issn.none.fl_str_mv ISSN: 1381-6128
EISSN: 1873-4286
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/27107
url https://doi.org/10.2174/1381612823666170918124419
https://repository.urosario.edu.co/handle/10336/27107
identifier_str_mv ISSN: 1381-6128
EISSN: 1873-4286
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 5963
dc.relation.citationIssue.none.fl_str_mv No. 38
dc.relation.citationStartPage.none.fl_str_mv 5955
dc.relation.citationTitle.none.fl_str_mv Current Pharmaceutical Design
dc.relation.citationVolume.none.fl_str_mv Vol. 23
dc.relation.ispartof.spa.fl_str_mv Current Pharmaceutical Design, ISSN: 1381-6128;EISSN: 1873-4286, Vol.23, No.38 (2017); pp. 5955-5963
dc.relation.uri.spa.fl_str_mv https://www.eurekaselect.com/155663/article
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Bentham Science Publishers
dc.source.spa.fl_str_mv Current Pharmaceutical Design
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390766784937984